Darglitazone

SKU: orb1305841

Description

Darglitazone (CP-86325) is a potent and selective PPAR-γ agonist used in research for its antidiabetic properties. It has demonstrated efficacy in modulating glucose and lipid metabolism in both in vitro assays and in vivo animal models of type 2 diabetes and insulin resistance.

Research Area

Metabolism Research, Molecular Biology

Key Properties

• CAS Number: 141200-24-0
• MW: 420.48
• Purity: 99.19% (May vary between batches)
• Formula: C₂₃H₂₀N₂O₄S
• SMILES: C(CC(=O)C1=CC=C(CC2SC(=O)NC2=O)C=C1)C=3N=C(OC3C)C4=CC=CC=C4
• Target: PPAR
• Solubility: 10% DMSO+90% Corn Oil:2.5 mg/mL (5.95 mM);Ethanol:≤ 5 mg/mL;DMSO:55 mg/mL (130.8 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Inhibitor, oral, inhibit, Diabetes, CP 86325, CP86325, CP-86325, Darglitazone, corticosterone, UCP2, thiazolidinedione, PPAR, PPARγ, PPAR-γ, Peroxisome proliferator-activated receptors

Quick Database Links

Gene Symbol

PPAR